Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.79 -0.03 (-3.09%)
As of: Sep 10, 2026 · 11:13 AM EDT

Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2025)

Biodexa Pharmaceuticals' (BDRX) quarterly Assets came in at $24.2 million in Q4 2025, up 27.47% year-over-year from $19.0 million in Q4 2024, and up 22.28% quarter-over-quarter from $19.8 million in Q2 2025.

Analysis

Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2025) Analysis & Trends

Biodexa Pharmaceuticals has disclosed Assets across 13 years of filings, most recently posting $24.2 million for Q4 2025.

  • In Q4 2025, Assets rose 27.47% year-over-year to $24.2 million; the TTM figure through Dec 2025 stood at $24.2 million (up 27.47% YoY), while the FY2025 annual figure was $24.0 million, up 26.87% from the prior year.
  • Assets came in at $24.2 million for Q4 2025 at Biodexa Pharmaceuticals, up from $19.8 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $24.2 million in Q4 2025 to a low of $6.5 million in Q4 2022.
  • Average Assets over 5 years is $15.1 million, with a median of $15.2 million recorded in 2021.
  • Year-over-year, Assets sank 62.77% in 2022 and surged 101.9% in 2023.
  • Over 5 years, Assets stood at $17.4 million in 2021, then slumped by 62.77% to $6.5 million in 2022, then jumped by 101.9% to $13.1 million in 2023, then jumped by 44.98% to $19.0 million in 2024, then gained by 27.47% to $24.2 million in 2025.
  • Per Business Quant data, the three most recent Assets figures were $24.2 million in Q4 2025, $19.8 million in Q2 2025, and $19.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 207.17 Bn 193.18 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 179.52 Bn 176.34 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 131.47 Bn 123.62 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 81.73 Bn 73.74 Bn 3.93 Bn 41.73 Bn
5 Argenx Se 61.16 Bn 55.98 Bn 1.37 Bn 10.03 Bn
6 Moderna 53.28 Bn 48.14 Bn 52.00 Mn 10.96 Bn
7 Alnylam Pharmaceuticals 33.06 Bn 29.76 Bn 992.69 Mn 5.56 Bn
8 Biogen 31.65 Bn 30.37 Bn 1.96 Bn 32.09 Bn
9 Roivant Sciences 29.30 Bn 29.30 Bn 1.16 Mn 5.31 Bn
10 Biodexa Pharmaceuticals 49.71 Mn 38.36 Mn - 24.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24.18 Mn
Jun 30, 2025 19.78 Mn
Dec 31, 2024 18.97 Mn
Jun 30, 2024 17.63 Mn
Dec 31, 2023 13.08 Mn
Jun 30, 2023 9.96 Mn
Dec 31, 2022 6.48 Mn
Jun 30, 2022 12.19 Mn
Dec 31, 2021 17.41 Mn
Jun 30, 2021 11.57 Mn
Dec 31, 2020 12.96 Mn
Jun 30, 2020 14.90 Mn
Dec 31, 2019 39.72 Mn
Jun 30, 2019 36.70 Mn
Dec 31, 2018 26.31 Mn
Jun 30, 2018 48.84 Mn
Dec 31, 2017 65.35 Mn
Jun 30, 2017 57.86 Mn
Dec 31, 2016 70.48 Mn
Jun 30, 2016 81.30 Mn